Clinical Trial Update: SK-NK Injection in Patients With Advanced Solid Tumors Accompanied by Malignant Ascites [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating SK-NK Injection in patients with advanced solid tumors and malignant ascites; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Ascites
• Solid Tumor

Drugs mentioned

• SK-NK Injection

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Solid Tumor, Malignant Ascites | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING